Celltrion USA’s commitment to meeting patient demand for affordable and effective biologicsByThomas Nusbickel, Chief Commercial Officer, Celltrion USAOctober 6th 2023Sponsored Content
Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars ByThomas Nusbickel, Chief Commercial Officer, Celltrion USAJuly 5th 2023Sponsored Content
